NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Thursday reported a loss of $37.4 million in its second quarter.

The New York-based company said it had a loss of 68 cents per share.

Intra-Cellular shares have risen 43 percent since the beginning of the year. The stock has increased 84 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ITCI at